299 related articles for article (PubMed ID: 34492555)
1. Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups - United States, 2004-2019.
Kariisa M; Seth P; Scholl L; Wilson N; Davis NL
Drug Alcohol Depend; 2021 Oct; 227():109001. PubMed ID: 34492555
[TBL] [Abstract][Full Text] [Related]
2. Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017.
Kariisa M; Scholl L; Wilson N; Seth P; Hoots B
MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):388-395. PubMed ID: 31048676
[TBL] [Abstract][Full Text] [Related]
3. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
Hoots B; Vivolo-Kantor A; Seth P
Addiction; 2020 May; 115(5):946-958. PubMed ID: 31912625
[TBL] [Abstract][Full Text] [Related]
4. Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999-2018.
Rawy M; Abdalla G; Look K
BMC Public Health; 2024 Jan; 24(1):112. PubMed ID: 38184563
[TBL] [Abstract][Full Text] [Related]
5. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021.
Friedman J; Shover CL
Addiction; 2023 Dec; 118(12):2477-2485. PubMed ID: 37705148
[TBL] [Abstract][Full Text] [Related]
6. Opioid and stimulant attributed treatment admissions and fatal overdoses: Using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992-2020.
Jones AA; Shearer RD; Segel JE; Santos-Lozada A; Strong-Jones S; Vest N; Teixeira da Silva D; Khatri UG; Winkelman TNA
Drug Alcohol Depend; 2023 Aug; 249():109946. PubMed ID: 37354584
[TBL] [Abstract][Full Text] [Related]
7. Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids.
Cano M; Huang Y
Drug Alcohol Depend; 2021 Jan; 218():108384. PubMed ID: 33158665
[TBL] [Abstract][Full Text] [Related]
8. Changing Trends in Drug Overdose Mortality in Kentucky: An Examination of Race and Ethnicity, Age, and Contributing Drugs, 2016-2020.
Slavova S; Freeman PR; Rock P; Brancato C; Hargrove S; Liford M; Quesinberry D; Walsh SL
Public Health Rep; 2023; 138(1):131-139. PubMed ID: 35184586
[TBL] [Abstract][Full Text] [Related]
9. The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis.
Estadt AT; White BN; Ricks JM; Lancaster KE; Hepler S; Miller WC; Kline D
Harm Reduct J; 2024 Jan; 21(1):13. PubMed ID: 38233924
[TBL] [Abstract][Full Text] [Related]
10. Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011-2021.
Spencer MR; Miniño AM; Garnett MF
NCHS Data Brief; 2023 Jul; (474):1-8. PubMed ID: 37486676
[TBL] [Abstract][Full Text] [Related]
11. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.
Mattson CL; Tanz LJ; Quinn K; Kariisa M; Patel P; Davis NL
MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(6):202-207. PubMed ID: 33571180
[TBL] [Abstract][Full Text] [Related]
12. Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid-Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas - United States, 2015-2017.
Lippold KM; Jones CM; Olsen EO; Giroir BP
MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(43):967-973. PubMed ID: 31671083
[TBL] [Abstract][Full Text] [Related]
13. Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.
Seth P; Scholl L; Rudd RA; Bacon S
MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(12):349-358. PubMed ID: 29596405
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic differences in US drug overdose mortality, 2017-2018.
Cano M
Addict Behav; 2021 Jan; 112():106625. PubMed ID: 32916612
[TBL] [Abstract][Full Text] [Related]
15. Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007-2019.
Townsend T; Kline D; Rivera-Aguirre A; Bunting AM; Mauro PM; Marshall BDL; Martins SS; Cerdá M
Am J Epidemiol; 2022 Mar; 191(4):599-612. PubMed ID: 35142341
[TBL] [Abstract][Full Text] [Related]
16. Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration.
Coughlin LN; Zhang L; Bohnert ASB; Maust DT; Goldstick J; Lin LA
Addiction; 2022 Apr; 117(4):998-1008. PubMed ID: 34648209
[TBL] [Abstract][Full Text] [Related]
17. Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019.
O'Donnell J; Gladden RM; Mattson CL; Hunter CT; Davis NL
MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1189-1197. PubMed ID: 32881854
[TBL] [Abstract][Full Text] [Related]
18. State-Level History of Overdose Deaths Involving Stimulants in the United States, 1999‒2020.
Kline D; Bunting AM; Hepler SA; Rivera-Aguirre A; Krawczyk N; Cerda M
Am J Public Health; 2023 Sep; 113(9):991-999. PubMed ID: 37556789
[No Abstract] [Full Text] [Related]
19. Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics - 25 States and the District of Columbia, 2019-2020.
Kariisa M; Davis NL; Kumar S; Seth P; Mattson CL; Chowdhury F; Jones CM
MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(29):940-947. PubMed ID: 35862289
[TBL] [Abstract][Full Text] [Related]
20. Racial/ethnic differences in opioid-involved overdose deaths across metropolitan and non-metropolitan areas in the United States, 1999-2017.
Lippold K; Ali B
Drug Alcohol Depend; 2020 Jul; 212():108059. PubMed ID: 32447173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
